Among the three, semaglutide is reported to have the longest terminal half-life in published human pharmacokinetic literature approximately 1 week (~145168 h) following subcutaneous administration (Yang & Yang, 2024)
Combining semaglutide with other weight loss medications or supplements is not recommendedespecially without medical supervision
Additionally, tirzepatide, a dual GLP-1 and GIP agonist (Mounjaro for diabetes, Zepbound for obesity) is another recent addition to this class of drugs
(27) Chang et al
If your request is denied, don't give up
Investigations assess its potential effects on cuprizone-associated demyelination, traumatic brain injury, neurotoxin-induced dopaminergic disruption, neurotransmitter regulation, and peripheral or central nerve regeneration